"Sustained Low Relapse Rate With Highly Variable B-Cell Repopulation Dynamics With Extended Rituximab Dosing Intervals in Multiple Sclerosis." Neurology - Neuroimmunology Neuroinflammation
10.1
(2023):
e200056.
Web. 24 Sept2023.
Advertisement